| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $2.8M | — | +22.4% |
| SG&A Expense | $2.6M | — | +22.6% |
| Operating Income | -$5.4M | — | -22.5% |
| Pre-tax Income | -$5.4M | — | -22.5% |
| Income Tax | $183K | — | +82.1% |
| Net Income | -$5.6M | — | -23.8% |
| EPS (Basic) | -$0.13 | — | +18.8% |
| EPS (Diluted) | -$0.13 | — | +18.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $16.5M | -20.6% | +82.3% |
| Current Assets | $18.2M | -18.1% | +63.4% |
| Total Assets | $18.7M | -17.9% | +61.2% |
| Current Liabilities | $3.9M | +15.9% | -22.7% |
| Long-term Debt | $374K | -6.8% | -12.6% |
| Total Liabilities | $4.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.7M | — | -23.7% |
| Financing Cash Flow | $404K | — | -83.1% |
| -19.0% |
| Stockholders' Equity | $14.0M | -24.6% | +142.3% |